RY
Ruchika Yogesh
Also known as: Ruchika Chakrabarty
Matestlab India Pvt. Ltd., Matestlab Inc., Banaras Hindu University, The Cureus Journal of Medical Sciences
Research areas: Medicine · Biochemistry · Phytochemicals and Antioxidant Activities · COVID-19 Clinical Research Studies · Alzheimer's disease research and treatments
0000-0001-8017-0840
Employment
-
Matestlab India Pvt. Ltd. Dirctor2026 - Present
-
AutoText AI Pvt. Ltd. Co-founder2023 - 2025
-
Matestlab Inc. Director2022 - Present
-
The Cureus Journal of Medical Sciences Senior copyeditor (Contract)2021 - Present
-
A US-based material testing service aggregator company Consultant2021 - 2023
-
Delhi Institute of Pharmaceutical Sciences and Research Visiting Faculty2014 - 2016
-
Ranbaxy Research Laboratories Senior Research Scientist2007 - 2014
Education
-
Banaras Hindu University Master in Science1999 - 2001
-
Banaras Hindu University Bachelor in Science1996 - 1999
Projects & Funding
Projects & funding information is unavailable.
Publications (17)
- Principles of Bioethics and Biosafety in Pharmaceuticals Save
- Signaling Pathways in Oxidative Stress-Induced Neurodegenerative Diseases: A Review of Phytochemical Therapeutic Interventions Save
- Development and Commercialization of Autotext AI as a Marketing Intelligence SaaS Product Save
- Efforts to Replace Methylene Chloride in Pharmaceutical Process Chemistry Save
- A detailed insight towards the role of microbial fuel cells for pharmaceutical wastewater treatment Save
- Removal of polyaromatic hydrocarbons using microbial fuel cells Save
- COVID-19 Challenge: A Quest for Effective Vaccine Strategies Against Circulating and Emerging SARS-CoV-2 Variants Save
- Citrus Flavonoids: Biological Activities, Implementation in Skin Health, and Topical Applications: A Review Save
- An Overview of Tetramethylpyrazine (Ligustrazine) and its Derivatives as Potent Anti-Alzheimer’s Disease Agents Save
- Research article writing — showcasing your work Save
- An Overview of Fungal Co-Infection Events Associated With COVID-19 Save
- Recent Advances in Tetrazole Derivatives as Potential Antiviral Agents Save
- Rational design, synthesis and evaluation of (6aR∗,11bS∗)-1-(4-fluorophenyl)-4-{7-[4-(4-fluorophenyl)-4-oxobutyl]1,2,3,4,6,6a,7,11b,12,12a(RS)-decahydropyrazino[2′,1′:6,1]pyrido[3,4-b]indol-2-yl}-butan-1-one as a potential neuroleptic agent Save
- Investigation of the barrier to the rotation of carbamate and amide C–N bonds in antidepressant (6aR∗,11bS∗)-7-[carbobenzyloxy-l-alanyl]-2-[(4-methylphenyl)sulfonyl]-1,2,3,4,6,6a,7,11b,2,12a(S)-decahydropyrazino[2′,1′:6,1]pyrido[3,4-b]indole by dynamic N… Save
- Synthesis and QSAR studies on hypotensive 1-[3-(4-substituted phenylthio) propyl]-4-(substituted phenyl) piperazines Save
- A convenient regiospecific synthesis of substituted 1,3,4,6,6a, 11b,12,12a-octahydro-2H,7H-pyrazino[2′1′:6,1]pyrido(3,4-b)indoles Save
- A CONVENIENT ROUTE FOR THE SYNTHESIS OF CIS-1-SUBSTITUTED 1,2,3,4,4a,5,11,11a-OCTAHYDRO-6H-PYRIDO[3,2-b]CARBAZOLES AND 4-SUBSTITUTED 1,2,3,4,4a,5,6,11c-OCTAHYDRO-7H-PYRIDO[2,3-c] CARBAZOLES AS POTENT DOPAMINE AGONISTS Save